M
40
3
ADI
54
4
AA
27
5
HIG
48
5
HBI
53
4
HOG
29
4
CVS
27
2
AES
47
4
ES
12
3
HP
44
14
PH
60
5
EMN
40
5
EQT
47
13
GD
42
4
NOV
45
2
UA
48
6
KMI
69
8
XRX
48
2
EXPD
29
2
KO
44
2
M
40
3
ADI
54
4
AA
27
5
HIG
48
5
HBI
53
4
HOG
29
4
CVS
27
2
AES
47
4
ES
12
3
HP
44
14
PH
60
5
EMN
40
5
EQT
47
13
GD
42
4
NOV
45
2
UA
48
6
KMI
69
8
XRX
48
2
EXPD
29
2
KO
44
2
Financhill
Back

Achieve Life Sciences Vs. Perspective Therapeutics Industry Stock Comparison

Sell
25

ACHV
Achieve Life Sciences

Last Price:
$3.69
Seasonality Move:
16.1%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
41.25%
Sell
25
Achieve Life Sciences (ACHV) is a Sell

Is Achieve Life Sciences a Buy, Sell or Hold?

  • The current Achieve Life Sciences [ACHV] share price is $3.70. The Score for ACHV is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • ACHV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.85. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ACHV Stock Price Chart

What is Achieve Life Sciences's stock price today?

  • The Achieve Life Sciences share price today is $3.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACHV is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

ACHV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 26.25 Sell
Chaikin Money Flow: -211588 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.07 - 4.51) Sell
Bollinger Bands (100): (4.25 - 4.85) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.39 Sell
Relative Strength Index (14 RSI): 19.38 Sell
Chaikin Money Flow: -1073375 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 5.45) Sell
Bollinger Bands (100): (6.72 - 15.04) Sell

ACHV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 4.04 Sell
20-day SMA: 4.29 Sell
50-day SMA: 4.55 Sell
200-day SMA: 4.66 Sell
8-day EMA: 4.02 Sell
20-day EMA: 4.22 Sell
50-day EMA: 4.43 Sell
200-day EMA: 4.62 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.2 Sell
20-day SMA: 3.62 Sell
50-day SMA: 7.99 Sell
200-day SMA: 12.2 Sell
8-day EMA: 3.18 Sell
20-day EMA: 4.2 Sell
50-day EMA: 6.97 Sell
200-day EMA: 10.01 Sell

Achieve Life Sciences Earnings Growth & ACHV Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.33 per share, and an increase next year of $0.08 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Achieve Life Sciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):